Q32 Bio Inc. financial data

Symbol
QTTB on Nasdaq
Industry
Pharmaceutical Preparations
Location
830 Winter Street, Waltham, MA
State of incorporation
DE
Fiscal year end
December 31
Former names
Homology Medicines, Inc. (to 3/22/2024)
Latest financial report
10-Q - Q3 2024 - Nov 7, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 473 % -26.2%
Debt-to-equity -485 % -1286%
Return On Equity 582 % +1254%
Return On Assets -112 % -238%
Operating Margin -8.77K % -111%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 12.2M shares -79%
Common Stock, Shares, Outstanding 12.1M shares -79%
Entity Public Float 45.8M USD -50.4%
Common Stock, Value, Issued 2K USD -66.7%
Weighted Average Number of Shares Outstanding, Basic 12.1M shares +3387%
Weighted Average Number of Shares Outstanding, Diluted 12.1M shares +3387%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 0 USD -100%
Revenue from Contract with Customer, Excluding Assessed Tax 1.16M USD -64%
Research and Development Expense 76.2M USD +50.8%
General and Administrative Expense 38.2M USD +151%
Operating Income (Loss) -131M USD -129%
Nonoperating Income (Expense) 1.22M USD
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -87.1M USD -7369%
Income Tax Expense (Benefit) 65K USD
Net Income (Loss) Attributable to Parent -120M USD -96.5%
Earnings Per Share, Basic 73.3 USD/shares +96.4%
Earnings Per Share, Diluted 65.9 USD/shares +96.4%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 89.1M USD +146%
Other Assets, Current 229K USD
Assets, Current 93.9M USD -11.9%
Property, Plant and Equipment, Net 1.49M USD
Operating Lease, Right-of-Use Asset 5.87M USD -69.9%
Other Assets, Noncurrent 40K USD
Assets 105M USD -25.4%
Accounts Payable, Current 1.26M USD -83.9%
Employee-related Liabilities, Current 3.47M USD -47.9%
Accrued Liabilities, Current 8.91M USD
Contract with Customer, Liability, Current 0 USD -100%
Liabilities, Current 14.4M USD -43.1%
Contract with Customer, Liability, Noncurrent 0 USD -100%
Operating Lease, Liability, Noncurrent 5.79M USD -78.2%
Other Liabilities, Noncurrent 55M USD
Liabilities 86.2M USD +66.3%
Accumulated Other Comprehensive Income (Loss), Net of Tax -1K USD +97.2%
Retained Earnings (Accumulated Deficit) -221M USD +58.1%
Stockholders' Equity Attributable to Parent 18.3M USD
Liabilities and Equity 105M USD -25.4%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -14.6M USD -16.4%
Net Cash Provided by (Used in) Financing Activities 99.3M USD +662207%
Net Cash Provided by (Used in) Investing Activities 168M USD
Common Stock, Shares Authorized 400M shares +100%
Common Stock, Shares, Issued 12.1M shares -79%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 5.47M USD -96%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 89.7M USD +114%
Deferred Tax Assets, Valuation Allowance 221M USD +23.2%
Deferred Tax Assets, Gross 222M USD +19.3%
Operating Lease, Liability 6.82M USD -75.9%
Depreciation 574K USD -46.5%
Payments to Acquire Property, Plant, and Equipment 0 USD -100%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -119M USD -96.1%
Lessee, Operating Lease, Liability, to be Paid 8.81M USD -78.8%
Property, Plant and Equipment, Gross 2.82M USD
Operating Lease, Liability, Current 1.03M USD -42.2%
Lessee, Operating Lease, Liability, to be Paid, Year Two 1.06M USD -76.8%
Lessee, Operating Lease, Liability, to be Paid, Year One 691K USD -39.1%
Operating Lease, Weighted Average Discount Rate, Percent 0.11 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 1.99M USD -84.9%
Lessee, Operating Lease, Liability, to be Paid, Year Three 1.09M USD -76.8%
Deferred Tax Assets, Operating Loss Carryforwards 88.6M USD +15.4%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 1.12M USD -76.9%
Additional Paid in Capital 239M USD -61.1%
Preferred Stock, Shares Outstanding 0 shares
Share-based Payment Arrangement, Expense 9.55M USD +139%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%